Introduction
The artificial urinary sphincter (AUS) was first described by Foley in 1943 . 1 The current generation model of AMS 800 (American Medical Systems, MN, U.S.) has been implanted since 1982. Indications for implantation of an AUS include postprostatectomy incontinence, neurogenic bladder dysfunction, intrinsic sphincter deficiency (ISD), and rare congenital causes of incontinence. 2 When looking specifically at female non-neurogenic stress urinary incontinence, recent studies demonstrate good long-term functional outcomes from the abdominal approach, with success rates of up to 94.4%. 3 Recent advances in minimally invasive surgery have mitigated the risks of abdominal surgery with the first laparoscopic implantation of AUS published in 2005. 4 The introduction of robotic-assisted laparoscopic (RAL) surgery brings distinct benefits of superior visualization, improved dexterity, and minimization of blood loss during deep pelvic dissection. 5 Hence, we set out to evaluate the role of robotic assistance in AUS implantation in a neurogenic bladder patient with concomitant surgery for pelvic organ prolapse (POP).
Case report
This patient is a 45-year-old female with persistent urinary incontinence. Initial urodynamic studies demonstrated stress urinary incontinence and she was unsuccessfully treated with an autologous fascial sling and subsequent periurethral bulking agent injection. Repeat urodynamic studies demonstrated absent sensation on filling cystometry and decreased detrusor pressure on pressure flow study. She required daily clean intermittent catheterizations (CIC) to reduce the amount of leakage. Her diagnosis of neurogenic bladder dysfunction was confirmed when she underwent spinal surgery for cauda equina syndrome later that year. On exam, she had grade 3 POP and was consented for combined RAL AUS implantation with hysterectomy and sacrocolpopexy.
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The patient received intravenous antibiotics and was given a general anesthetic. She was placed in dorsal lithotomy position. Under Trendelenburg position, direct entry was made using a 12mm disposable trocar supra-umbilically. Two 8mm robotic ports were placed on the left; a third robotic port and a 12mm assistant port were placed on the right. After parallel docking of the da Vinci Surgical System (Intuitive Surgical, CA, USA), robotic monopolar scissors, bipolar grasper, and ProGrasp TM forceps were inserted.
The operation began with RAL bilateral salpingectomy, right oophorectomy, hysterectomy, and sacrocolpopexy. The techniques of RAL sacrocolpopexy have been previously described. 6 Entry into the pre-vesical space was made by incising the parietal peritoneum between the medial umbilical ligaments. The bladder neck was freed from perivesical fat and the endopelvic fascia at this level was sharply incised laterally. The vaginal surgeon who is experienced in the implantation of AUS introduced two fingers in the vagina to direct placement of the robotic instrument just below the urethra. Circumferential dissection of the urethrovaginal space was accomplished progressively with ProGrasp TM forceps from both sides of the bladder neck (Fig. 1) . Cystoscopy was performed to confirm mucosal integrity. The tape measurer was introduced via the assistant port to measure the size of the cuff and was exchanged with the pressurized cuff. The pressure regulating balloon was introduced into the pre-vesical space via a separate suprapubic incision (Fig. 2) . The control pump was introduced to the labia majora with blunt dissection. All tubing connections were made at the suprapubic site and buried subcutaneously. The peritoneum overlying the pre-vesical space was closed with absorbable barbed sutures. The sphincter mechanism was cycled then deactivated.
Results
Estimated blood loss was minimal. There were no intraoperative complications. Total operative time was 215min. AUS implantation duration was 99min including 20min dedicated to the circumferential dissection of the bladder neck. The patient was discharged home on postoperative day (POD) 1. She required a 14F indwelling catheter for 14 days given her neurogenic bladder dysfunction and continued with daily CIC after catheter removal. AUS was activated at 6 weeks postoperatively. At 3 months, she did not require any incontinence pads. Discussion AUS has been used as an effective device for women with severe, refractory incontinence for several decades. There is prospective data demonstrating long term success of 94.4% after 10 years of follow-up from an abdominal approach in women with ISD. 3 Laparoscopic and RAL approaches have been introduced only recently but preliminary results show that functional outcomes mirror those of abdominal approaches, albeit with significantly less morbidities. Success rates, when defined as social continence (1 pad/day or less), approach 100% in the largest RAL series. 7 Peyronnet et al. compared perioperative outcomes between abdominal and
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Zhao et al Techniques -RAL implantation of artificial urinary sphincter RAL implantation of AUS and found a statistically lower postoperative complication rate and a trend toward lower intraoperative complications, decreased blood loss, and shorter lengths of hospitalization in the RAL group. 8 The most difficult step of the procedure is the development of the urethrovaginal plane due to the absence of a natural plane between the bladder and vagina, especially with scarring from previous anti-incontinence surgeries. 2 Circumferential dissection of the bladder neck can cause perforations into the bladder, urethra, or vagina, which are known risk factors of sphincter erosion and device explantation. 9 In RAL series, intraoperative injury and explantation rates approach 40% and 30%, respectively. 7 It is crucial to have a surgeon experienced in AUS implantation providing vaginal guidance to the robotic surgeon. Robotic assistance is helpful by providing superior 3-D visualization and orientable instruments. We found that this step alone took 20min to accomplish safely while another series found that it can take up to 66min.
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Compared to other series, our duration of implantation was shorter at 99min, which could be attributed to our 2-surgeon approach. Our patient was also safely discharged home on POD 1, by taking advantage of the minimally invasive nature of the procedure. Earlier discharge and shorter hospital stay may provide justification for the high costs associated with robotic surgery. Finally, our report presented a patient with neurogenic bladder dysfunction and hence the prolonged catheterization and continuation of CIC postoperatively were therefore expected.
Conclusion
This report is the first published RAL implantation of AUS in Canada and demonstrates that it can be safely and efficiently performed with other pelvic procedures in a minimally invasive fashion, while providing the patient with benefits of shorter hospital stay and functional continence at 3 months. Techniques -RAL implantation of artificial urinary sphincter 
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Zhao et al Techniques -RAL implantation of artificial urinary sphincter Fig. 2 . Placement of the cuff and pressure regulating balloon in the pre-vesical space. A 7 cm cuff was placed around the bladder neck after it was measured with a tape measurer. A 61-70 cm H 2 O pressure regulating balloon was introduced into the pre-vesical space via a separate suprapubic incision.
